Allogeneic ABCB5-positive Stem Cells for Treatment of Acute-on-Chronic Liver Failure
Clinical trial NCT03860155 · TERMINATED
Trial details
- NCT number
- NCT03860155
- Sponsor
- RHEACELL GmbH & Co. KG
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-22
- Primary completion
- 2021-03-26
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.